首页> 外文期刊>Annals of Coloproctology >Is a Short Distal Resection Margin of Less than One Centimeter in a Sphincter-saving Resection for Rectal Cancer Oncologically Safe?
【24h】

Is a Short Distal Resection Margin of Less than One Centimeter in a Sphincter-saving Resection for Rectal Cancer Oncologically Safe?

机译:在保留括约肌的切除术中,直肠癌的短距离切除余量小于一厘米是否在肿瘤学上安全?

获取原文
           

摘要

Purpose Sphincter preservation is one of the main goals in the treatment of rectal cancer. The aim of this study was to evaluate the oncologic safety of a sphincter-saving resection with a distal resection margin of less than 1 cm. Methods Two hundred forty-eight patients who underwent a sphincter-saving resection between June 1989 and December 2002 and who had a confirmed distal resection margin of less than 1 cm on pathologic examination were included. All patients were evaluated for local and systemic recurrences. Results The median follow-up period was 45 (6~144) months. The mean length of distal resection margin was 0.79±0.26 cm. Lower rectalcancer was most common (56.5%). Forty patients (16.1%) experienced recurrence. The local recurrence rate was 3.6%, systemic recurrence rate was 11.7%, and the combined local and systemic recurrence rate was 0.4%. In systemic recurrence, the liver was the most common site, followed by the lung. Among stage II & III groups, patients who underwent adjuvant chemoradiotherapy experienced significantly lower local recurrence compared to patients in the chemotherapyonly or the no-adjuvant group (2.6%, 12.9%, 8.7%, P=0.05). The length of distal resection margin, the total mesorectal excision, the location of tumor, sex, histology, and stage were not associated with local recurrence. Conclusions A distal resection margin of less than 1 cm in a sphincter-saving resection showed acceptableoncologic outcomes. Adjuvant chemoradiotherapy were beneficial to reduce local recurrence in the stage II and the stage III groups.
机译:目的保留括约肌是直肠癌治疗的主要目标之一。这项研究的目的是评估保留远端括约肌切缘小于1 cm的保留括约肌的切除术的肿瘤学安全性。方法包括1989年6月至2002年12月间行保留括约肌切除术并经病理检查证实远端切除切缘小于1 cm的48例患者。对所有患者进行局部和全身复发的评估。结果中位随访期为45(6〜144)个月。远端切除切缘的平均长度为0.79±0.26 cm。下直肠癌是最常见的(56.5%)。 40例患者(16.1%)经历了复发。局部复发率为3.6%,全身复发率为11.7%,局部和全身合并复发率为0.4%。在全身性复发中,肝脏是最常见的部位,其次是肺。在第二和第三阶段组中,接受辅助放化疗的患者的局部复发率显着低于仅接受化疗或无辅助化疗的患者(2.6%,12.9%,8.7%,P = 0.05)。远端切除边缘的长度,全部直肠系膜切除,肿瘤的位置,性别,组织学和分期与局部复发无关。结论在保留括约肌的切除术中,远端切除术边缘小于1 cm表现出可接受的肿瘤学结果。辅助放化疗对减少Ⅱ期和Ⅲ期组的局部复发是有益的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号